ReviewESMO open2020
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis.
Iñaki Etxeberria et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
112 papers cite itlatest 60 shown
this papercites it
ReviewESMO open2020
Iñaki Etxeberria et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.